Surrey Professor shares best practice with Canadian Health Professionals
Monday 9 November 2009
Surrey’s Professor Tom Quinn has recently returned from British Columbia, Canada after offering his expertise in heart attack and stroke care. The Health Professionals' Roundtable for Strategy (HPRSTM) event was organised by the Canadian College of Health Service Executives and aimed to share best practice and develop strategies to achieve more positive outcomes in treatment and reduce patient mortality.
The event, which took place in Victoria, British Columbia on 19 September, was sponsored by Roche so that it could learn how it can play a role to make a system difference and raise awareness to improve quality of care and patient safety for Stroke and AMI (Acute Myocardial Infarction) patients.
Founded in 1970, the Canadian College of Health Service Executives is a national, non-profit, professional association dedicated to developing, promoting, advancing and recognising excellence in health leadership. Their 3,000 individual and 80 corporate members work in all health sectors across Canada.
The Health Professionals' Roundtable for Strategy (HPRSTM) is an exclusive think tank of executives grouped in client panels to express their views and opinions based on their own knowledge and experience in the health sector industry. When the College's corporate members expresses a need for focused, yet informal, advice concerning their marketing strategies; market dynamics; environments; business models; approach to market; and existing and/or proposed products and/or services, the College identifies health service executives willing to share their time and talents with participating corporate clients for this purpose. All HPRSTM sessions are completely confidential and all panellists are bound to the College Standards of Ethical Conduct.
Mike Dell, Director Thrombolytics from Roche commented about the event: "This was a unique opportunity for Roche to get first hand perspectives on acute stroke treatment from both clinical experts and by health care executives. What we learned is that there is strong interest by stakeholders to advance stroke treatment in a way that delivers better patient outcomes."
